Position in RLAY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$652,451
+$340,506 QoQ
Shares Held
65,573
+77.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. RLAY ranks #127 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in RLAY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $652,451 | 65,573 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $311,945 | 36,873 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $192,477 | 36,873 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,580 | 36,873 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $96,607 | 36,873 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $151,916 | 36,873 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $261,060 | 36,873 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $240,411 | 36,873 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $309,937 | 37,342 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $410,815 | 37,313 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $314,289 | 37,371 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $469,416 | 37,374 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $616,307 | 37,420 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $273,849 | 18,330 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $271,348 | 12,130 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $281,098 | 16,782 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $536,136 | 17,004 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $886,941 | 24,240 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,212,590 | 92,930 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,076,703 | 98,092 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,724,762 | 486,611 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||